Advanced

Human Papillomavirus vaccination: Immunological and epidemiological studies

Ryding, Janka LU (2008) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2008:57.
Abstract
This thesis has evaluated the immunological- and epidemiological aspects of human papillomavirus transmission dynamics and its effect on circumcision.



Effective prophylactic vaccines are based on type-specific neutralizing antibodies. A major neutralizing epitope is defined by the monoclonal antibody H16.V5. To investigate the importance of this epitope for overall immunogenicity of HPV16, we engineered HPV16 virus-like particles devoid of the H16.V5 epitope by site-directed mutagenesis of 10 non-conserved, surface exposed residues. Removal of the V5-defined epitope had only marginal effect on antigenic reactivity with antibodies in sera from infected subjects, but affected immunogenicity in experimental immunization of... (More)
This thesis has evaluated the immunological- and epidemiological aspects of human papillomavirus transmission dynamics and its effect on circumcision.



Effective prophylactic vaccines are based on type-specific neutralizing antibodies. A major neutralizing epitope is defined by the monoclonal antibody H16.V5. To investigate the importance of this epitope for overall immunogenicity of HPV16, we engineered HPV16 virus-like particles devoid of the H16.V5 epitope by site-directed mutagenesis of 10 non-conserved, surface exposed residues. Removal of the V5-defined epitope had only marginal effect on antigenic reactivity with antibodies in sera from infected subjects, but affected immunogenicity in experimental immunization of mice, with reduced induction of both antibody responses and CTL responses.



A serological survey of HPV16 antibody prevalence by age and sex in Sweden was performed and used it as a basis for modeling the optimal vaccination strategies in this population. By the year 2055, vaccination of females starting at age 12 in 2008 was most efficient, estimated to prevent 5.8 million cumulative HPV16 infections. Catch-up programs had a strong additional preventive effect. Vaccination also targeting males increased protective effect by about 4 percent, but had lower preventive effect per vaccination given. Addition of an HPV serosurvey to existing models and data has enabled us to estimate effect of different vaccination strategies, optimised to the HPV epidemiology in our population.



The age-dependent seroprevalence of HPV6, 11, 16, 18, and 52 infection was investigated and further used to asses the transmission dynamics in a representative Swedish population. Analyses of age-specific prevalence revealed different patterns for high- and low-risk HPV infections between females and males.



Circumcision has been reported to protect against infection with human papillomavirus in men, but results have been inconsistent. We followed males in a birth cohort born in Dunedin, New Zealand from age 3 to 32 years. Circumcision was not found to be protective, with the adjusted odds ratio (95% confidence interval) for HPV6/11/16/18 seropositivity among the circumcised compared with the uncircumcised being 1.4 (0.89-2.2). (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • Olin, Patrick, Swedish Institute for Infectious Disease Control
organization
publishing date
type
Thesis
publication status
published
subject
keywords
enzyme-linked immunosorbent assay (ELISA), Human Papillomavirus (HPV), parallel line method (PLL), mathematical modeling, virus-like particles (VLPs), prevalence, serology
in
Lund University, Faculty of Medicine Doctoral Dissertation Series
volume
2008:57
pages
159 pages
publisher
Department of Laboratory Medicine, Lund University
defense location
Pathology Lecture Hall, Entrance 78, University Hospital MAS, Malmö
defense date
2008-05-26 09:00
ISSN
1652-8220
ISBN
978-91-86059-10-1
language
English
LU publication?
yes
id
f581f4ff-1fc4-440d-83ff-aff132bd6258 (old id 1145061)
date added to LUP
2008-04-25 13:20:59
date last changed
2016-09-19 08:44:50
@phdthesis{f581f4ff-1fc4-440d-83ff-aff132bd6258,
  abstract     = {This thesis has evaluated the immunological- and epidemiological aspects of human papillomavirus transmission dynamics and its effect on circumcision. <br/><br>
<br/><br>
Effective prophylactic vaccines are based on type-specific neutralizing antibodies. A major neutralizing epitope is defined by the monoclonal antibody H16.V5. To investigate the importance of this epitope for overall immunogenicity of HPV16, we engineered HPV16 virus-like particles devoid of the H16.V5 epitope by site-directed mutagenesis of 10 non-conserved, surface exposed residues. Removal of the V5-defined epitope had only marginal effect on antigenic reactivity with antibodies in sera from infected subjects, but affected immunogenicity in experimental immunization of mice, with reduced induction of both antibody responses and CTL responses. <br/><br>
<br/><br>
A serological survey of HPV16 antibody prevalence by age and sex in Sweden was performed and used it as a basis for modeling the optimal vaccination strategies in this population. By the year 2055, vaccination of females starting at age 12 in 2008 was most efficient, estimated to prevent 5.8 million cumulative HPV16 infections. Catch-up programs had a strong additional preventive effect. Vaccination also targeting males increased protective effect by about 4 percent, but had lower preventive effect per vaccination given. Addition of an HPV serosurvey to existing models and data has enabled us to estimate effect of different vaccination strategies, optimised to the HPV epidemiology in our population. <br/><br>
<br/><br>
The age-dependent seroprevalence of HPV6, 11, 16, 18, and 52 infection was investigated and further used to asses the transmission dynamics in a representative Swedish population. Analyses of age-specific prevalence revealed different patterns for high- and low-risk HPV infections between females and males. <br/><br>
<br/><br>
Circumcision has been reported to protect against infection with human papillomavirus in men, but results have been inconsistent. We followed males in a birth cohort born in Dunedin, New Zealand from age 3 to 32 years. Circumcision was not found to be protective, with the adjusted odds ratio (95% confidence interval) for HPV6/11/16/18 seropositivity among the circumcised compared with the uncircumcised being 1.4 (0.89-2.2).},
  author       = {Ryding, Janka},
  isbn         = {978-91-86059-10-1},
  issn         = {1652-8220},
  keyword      = {enzyme-linked immunosorbent assay (ELISA),Human Papillomavirus (HPV),parallel line method (PLL),mathematical modeling,virus-like particles (VLPs),prevalence,serology},
  language     = {eng},
  pages        = {159},
  publisher    = {Department of Laboratory Medicine, Lund University},
  school       = {Lund University},
  series       = {Lund University, Faculty of Medicine Doctoral Dissertation Series},
  title        = {Human Papillomavirus vaccination: Immunological and epidemiological studies},
  volume       = {2008:57},
  year         = {2008},
}